Search
  • Maple Tree

Navigating COVID-19 in the Cannabis industry in the UK


In an article for Cannabis Industry Journal, Professor Mike Barnes discusses the impact of Covid-19 on the CBD and medical cannabis industries in the UK.


"As the epidemic continues into May, there has been no shortage of scammers attempting to try and short-change a fearful, confused population. Unfortunately, the cannabis industry has seen some shameful claims by CBD and hemp companies, notably in the US, who claimed their products could cure or fight off the symptoms of COVID-19.


CBD has been positioned as having several positive health effects by manufacturers and retailers – most notably in reducing pain and inflammation, decreasing anxiety and helping sleep – which may be on the rise within this unsettling environment.


The International Association for Cannabinoid Medicine (IACM), issued a statement on the coronavirus pandemic saying, “there is no evidence that individual cannabinoids or cannabis preparations protect against infection … or could be used to treat COVID-19.” Trials have been launched in Israel to explore whether CBD’s anti-inflammatory properties can be an effective COVID-19 treatment. Until this has been clinically proven, cannabis firms must not make unsupported claims."


Continue reading: https://cannabisindustryjournal.com/feature_article/navigating-covid-19-in-the-cannabis-industry-in-the-uk/

Recent Posts

See All

Cannabis farm backed by British Lord raises £1.6m

Professor Mike Barnes speaks to Sifted about medical cannabis in the UK. "Professor Mike Barnes was the first doctor in the UK to prescribe cannabis. He says that private clinics are seeing a 30% incr

Maple Tree Logo

Global Medical Cannabis Experts

Contact

Start a conversation with Maple Tree.

Learn more about our services and how we can help your medical cannabis business develop. Contact us via the form or email info@mapletreeconsultants.co.uk.

©2020 by Maple Tree Med Can Ltd. Company no. 11998700.

  • Twitter